Literature DB >> 10788834

Life cycle of Trypanosoma cruzi (Y strain) in mice.

P L Pinto1, R Takami, E V Nunes, C S Guilherme, O C Oliveira, J Gama-Rodrigues, M Okumura.   

Abstract

Since 1958, we have studied experimental Chagas' disease (CD) by subcutaneous inoculation of 1,000 blood forms of Trypanosoma cruzi (Y strain) in Balb/C. mice. Evolution of parasitemia remained constant, beginning on the 5th and 6th day of the disease, increasing progressively, achieving a maximum on about the 30th day. After another month, only a few forms were present, and they disappeared from the circulation after the third month, as determined from direct examination of slides and the use of a Neubauer Counting Chamber. These events coincided with the appearance of amastigote nests in the tissues (especially the cardiac ones), starting the first week, and following the Gauss parasitemia curve, but they were not in parallel until the chronic stage. In 1997, we began to note the following changes: Parasites appeared in the circulation during the first week and disappeared starting on the 7th day, and there was a coincident absence of the amastigote nests in the tissues. A careful study verified that young forms in the evolutionary cycle of T. cruzi (epi + amastigotes) began to appear alongside the trypomastigotes in the circulation on the 5th and 7th post-inoculation day. At the same time, rounded, oval, and spindle shapes were seen circulating through the capillaries and sinusoids of the tissues, principally of the hematopoietic organs. Stasis occurs because the diameter of the circulating parasites is greater than the vessels, and this makes them more visible. Examination of the sternal bone marrow revealed young cells with elongated forms and others truncated in the shape of a "C" occupying the internal surface of the blood cells that had empty central portions (erythrocytes?). We hypothesize that there could be a loss of virulence or mutation of the Y strain of Trypanosoma cruzi.

Entities:  

Mesh:

Year:  1999        PMID: 10788834     DOI: 10.1590/s0041-87811999000500002

Source DB:  PubMed          Journal:  Rev Hosp Clin Fac Med Sao Paulo        ISSN: 0041-8781


  4 in total

Review 1.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Heterogeneous infectiousness in guinea pigs experimentally infected with Trypanosoma cruzi.

Authors:  Ricardo Castillo-Neyra; Katty Borrini Mayorí; Renzo Salazar Sánchez; Jenny Ancca Suarez; Sherrie Xie; Cesar Náquira Velarde; Michael Z Levy
Journal:  Parasitol Int       Date:  2015-10-22       Impact factor: 2.230

3.  Bioluminescent imaging of Trypanosoma cruzi infection.

Authors:  Kenneth V Hyland; Sofya H Asfaw; Cheryl L Olson; Melvin D Daniels; David M Engman
Journal:  Int J Parasitol       Date:  2008-04-25       Impact factor: 3.981

4.  Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi.

Authors:  Denise Lessa Aleixo; Fabiana Nabarro Ferraz; Erika Cristina Ferreira; Marta de Lana; Mônica Lúcia Gomes; Benício Alves de Abreu Filho; Silvana Marques de Araújo
Journal:  BMC Res Notes       Date:  2012-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.